Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Daily News

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Caitlin E. Cox

January 07, 2019

Advertisement

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Long-term Watchman Data Reassure: CAP and CAP2 Registries

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content